NovaBridge Biosciences (NBP) Non-Current Assets (2018 - 2025)

NovaBridge Biosciences (NBP) has 8 years of Non-Current Assets data on file, last reported at $43.0 million in Q4 2025.

• Quarterly Non-Current Assets rose 19.49% year-over-year to $43.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $162.4 million (down 2.27% YoY) and the FY2025 annual result came in at $43.0 million, up 19.49% from the prior year.
• Non-Current Assets fell to $43.0 million in Q4 2025 per NBP's latest filing, from $44.6 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $209.5 million in Q4 2023 and bottomed at $23.3 million in Q2 2024.
• The 5-year median for Non-Current Assets is $44.6 million (2025), against an average of $90.4 million.
• The widest annual swing landed in 2021, when Non-Current Assets surged 187.68%; it then sank 82.82% in 2024.
• Tracing NBP's Non-Current Assets over 5 years: stood at $188.8 million in 2021, then gained by 6.67% to $201.4 million in 2022, then climbed by 4.01% to $209.5 million in 2023, then slumped by 82.82% to $36.0 million in 2024, then increased by 19.49% to $43.0 million in 2025.
• Per Business Quant, the three latest NBP Non-Current Assets figures stand at $43.0 million (Q4 2025), $44.6 million (Q3 2025), and $39.1 million (Q2 2025).

Peer Comparison